Leslie Hulvershorn, M.D., M.Sc.
Leslie A. Hulvershorn, M.D., M.Sc.
|Personal Statement||Using functional brain imaging (fMRI), I am working to learn more about the neurobiology underling emotional difficulties in children and adolescents with externalizing disorders such as ADHD and oppositional defiant disorder. I very much enjoy working with children and their families to help clarify their diagnoses, establish a treatment plan and maintain a long term relationship with them as their treating psychiatrist. I am committed to a research program which may ultimately inform the prevention of common later-life outcomes such as substance use and depression.|
|Education||Undergraduate: Indiana University, B.S. in Neuroscience
Graduate School: University of Oxford, M.S.c in Auditory Neuroscience
Medical School: Indiana University School of Medicine
Residency: Indiana University School of Medicine, Academic Track
Fellowship: New York University School of Medicine, NYU Child Study Center, Research Track
American Board of Psychiatry and Neurology-General Psychiatry
Board Eligible, American Board of Psychiatry and Neurology-Child and Adolescent Psychiatry
Certified in Addiction Medicine by the American Board of Addiction Medicine
|Current Academic Interests||Teaching: I enjoy teaching medical students, general psychiatry residents, child psychiatry fellows and addictions psychiatry fellows as they rotate through the Pediatric Mood Disorders Clinic at the Riley Hospital Child and Adolescent Psychiatry Clinic. In addition, I supervise trainees who are collaborating on our translational research projects.
Clinical: As Chief of the Pediatric Mood Disorders Clinic, I evaluate and treat children and adolescents with mood disorders such as major depression, bipolar disorder and mood symptoms associated with disruptive behavior disorders (ADHD, ODD and conduct disorder). Our Clinic’s team approach includes psychopharmacology, psychotherapy and family-focused interventions.
Research: I am currently the principal investigator on several pediatric neuroimaging research projects. We are funded to examine the impact of methylphenidate treatment on corticolimbic brain connectivity in children with ADHD. We are also studying brain circuitry in a group of children who are at high risk for the development of addictions.